Clinical Trial Update: A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety, tolerability, and preliminary efficacy of CC-90011 in combination with cisplatin and etoposide as first-line therapy for exte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CC-90011
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Celgene | Conditions: Small Cell Lung Carcinoma | Phase 1 | Status: COMPLETED